1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Middle East North Africa Pharmaceutical Market Forecasts to 2018

Middle East North Africa Pharmaceutical Market Forecasts to 2018

  • November 2013
  • -
  • Espicom Business Intelligence
  • -
  • 62 pages

The global pharmaceutical market is forecast to be worth over US$1,250 billion by 2018 - but where are the key opportunities? And how does Middle East North Africa fit into this global outlook?

This analysis report, Middle East North Africa Pharmaceutical Market Forecasts to 2018 (published November 2013), is an essential resource for business forecasters, marketing planners, the investment community and anyone looking to understand the future outlook for the challenging pharmaceutical industry within this region.

You will benefit from:

• Growth forecasts to 2018 for 13 key country markets
• Comparative data on a regional basis
• Rankings by indicators allowing ‘at a glance’ benchmarking of countries
• Detailed information on each market
• PDF delivery with Excel data pack
• Easily exported data to enhance your business plans


Each individual country market provides detail and forecasts at a national level, with focus for key pharmaceutical product areas.

This report will show you growth forecasts to 2018 for 13 key country markets and across Middle East North Africa- allowing you to compare and assess the opportunities and challenges that will arise for your business. With an in-depth look at this regional market, you can better assess the region (and each country’s future potential and reflect this with strategic planning and investment decisions.




Table Of Contents

Middle East North Africa Pharmaceutical Market Forecasts to 2018
CONTENTS

FOREWORD iii

NOTES ON METHODOLOGY v

MARKET DATA 1

MENA: Pharmaceutical Market by Category 2
MENA: Pharmaceutical Market by Country (US$ bn) 3
MENA: Pharmaceutical Market by Country (EUR bn) 3
MENA: Pharmaceutical Market by Country, Per Capita (US$) 4
MENA: Pharmaceutical Market by Country, % of GDP 4
MENA: Pharmaceutical Market by Country, % of Health Expenditure 4
MENA: Prescription Drug Market by Country (US$ bn) 5
MENA: Prescription Drug Market by Country (EUR bn) 5
MENA: Prescription Drug Market by Country, Per Capita (US$) 5
MENA: Prescription Drug Market by Country, % of GDP 6
MENA: Prescription Drug Market by Country, % of Total Market 6
MENA: Patented Drug Market by Country (US$ bn) 6
MENA: Patented Drug Market by Country (EUR bn) 7
MENA: Patented Drug Darket by Country, Per Capita, (US$) 7
MENA: Patented Drug Market by Country, % of Prescription Market 7
MENA: Patented Drug Market by Country, % of Total Market 8
MENA: Generic Drug Market by Country (US$ bn) 8
MENA: Generic Drug Market by Country (EUR bn) 8
MENA: Generic Drug Market by Country, Per Capita, (US$) 9
MENA: Generic Drug Market by Country, % of Prescription Market 9
MENA: Generic Drug Market by Country, % of Total Market 9
MENA: Over-the-counter Medicine Market by Country (US$ bn) 10
MENA: Over-the-counter Medicine Market by Country (EUR bn) 10
MENA: Over-the-counter Medicine Market by Country, Per Capita, (US$) 10
MENA: Over-the-counter Medicine Market by Country, % of GDP 11
MENA: Over-the-counter Medicine Market by Country, % of Total Market 11

HEALTHCARE EXPENDITURE 13

MENA: Healthcare Expenditure by Category, 2009-18 14
MENA: Health Expenditure by Country (US$ bn) 15
MENA: Health Expenditure by Country (EUR bn) 15
MENA: Health Expenditure by Country, Per Capita, (US$) 15
MENA: Health Expenditure by Country, as % of GDP 16
MENA: Government Health Expenditure by Country (US$ bn) 16
MENA: Government Health Expenditure by Country (EUR bn) 16
MENA: Government Health Expenditure by Country, % of GDP 17
MENA: Government Health Expenditure by Country, % Total Health Expenditure 17
MENA: Private Health Expenditure by Country (US$ bn) 17
MENA: Private Health Expenditure by Country (EUR bn) 18
MENA: Private Health Expenditure by Country, % of GDP 18
MENA: Private Health Expenditure by Country, % Total Health Expenditure 18

Gross Domestic Product 19
MENA: GDP by Country (US$ bn) 20
MENA: GDP Per Capita by Country (US$) 21

POPULATION 23

MENA: Population by Country (mn) 24
MENA: Population Aged 65 and Over by Country (%) 24

COUNTRY DATA 25

Algeria Basic Data 26
Algeria: Pharmaceutical Market by Category 27
Bahrain Basic Data 28
Bahrain: Pharmaceutical Market by Category 29
Egypt Basic Data 30
Egypt: Pharmaceutical Market by Category 31
Iran Basic Data 32
Iran: Pharmaceutical Market by Category 33
Israel Basic Data 34
Israel: Pharmaceutical Market by Category 35
Jordan Basic Data 36
Jordan: Pharmaceutical Market by Category 37
Kuwait Basic Data 38
Kuwait: Pharmaceutical Market by Category 39
Lebanon Basic Data 40
Lebanon: Pharmaceutical Market by Category 41
Morocco Basic Data 42
Morocco: Pharmaceutical Market by Category 43
Oman Basic Data 44
Oman: Pharmaceutical Market by Category 45
Qatar Basic Data 46
Qatar: Pharmaceutical Market by Category 47
Saudi Arabia Basic Data 48
Saudi Arabia: Pharmaceutical Market by Category 49
UAE Basic Data 50
UAE: Pharmaceutical Market by Category 51

APPENDIX: SOURCES 53

General Sources 53

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

North America Insulin Delivery Market Outlook to 2022

North America Insulin Delivery Market Outlook to 2022

  • $ 5995
  • Industry report
  • January 2017
  • by Global Data

North America Insulin Delivery Market Outlook to 2022 Summary GlobalData’s new report, "North America Insulin Delivery Market Outlook to 2022", provides key market data on the North America Insulin Delivery ...

North America Vision Care Market Outlook to 2022

North America Vision Care Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

North America Vision Care Market Outlook to 2022 Summary GlobalData’s new report, "North America Vision Care Market Outlook to 2022", provides key market data on the North America Vision Care market. ...


Download Unlimited Documents from Trusted Public Sources

Global Therapy Market

  • January 2017
    32 pages
  • Therapy  

    Targeted Therap...  

    Monoclonal Anti...  

  • World  

View report >

Insulin Market and Diabetes Statistics in the US

  • January 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Diabetes Statistics

  • January 2017
    10 pages
  • Diabetes  

    Therapy  

View report >

Related Market Segments :

Pharmaceutical

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.